Inflammation and free radicals in tumor development and progression

REFERENCES

• Parkin DM, Srivatanakul P, Khlat M et al. Liver cancer in Thailand. I. A case-control study of cholangiocarcinoma. Int J Cancer 1991; 48: 329–332.
   PubMed Web of Science ®Google Scholar
• Shindo K. Significance of Schistosomiasis japonica in the development of cancer of the large intestine: report of a case and review of the literature. Dis Colon Rectum 1976; 19: 460–469.
   PubMed Web of Science ®Google Scholar
• Srivatanakul P, Ohshima H, Khlat M et al. Opistorchis viverrini infestation and endogenous nitrosamines as risk factors for cholangiocarcinoma in Thailand. Int J Cancer 1991; 48: 821–825.
   PubMed Web of Science ®Google Scholar
• Kantor AF, Hartge P, Hoover RN et al. Urinary tract infection and risk of bladder cancer. Am J Epidemiol1984; 119: 510-515.
   PubMed Web of Science ®Google Scholar
• Yoshida N, Granger DN, Evans Jr DJ et al. Mechanisms involved in Helicobacter pylori-induced inflammation. Gastroenterology 1993; 105: 1431–1440.
   PubMed Web of Science ®Google Scholar
• Daniel LN, Mao Y, Saffiotti U. Oxidative DNA damage by crystalline silica. Free Radic Biol Med 1993; 14: 463–472.
   PubMed Web of Science ®Google Scholar
• Rom WN, Travis WD, Brody AR. Cellular and molecular basis of the asbestos-related diseases. Am Rev Respir Dis 1991; 143: 408–422.
   PubMed Web of Science ®Google Scholar
• Levin B. Ulcerative colitis and colon cancer: biology and surveillance. J Cell Biochem Suppl 1992; 16G: 47–50.
   PubMedGoogle Scholar
• Choi PM, Zelig MP. Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut 1994; 35: 950–954.
   PubMed Web of Science ®Google Scholar
• Ames BN, Shigenaga M, Hagen TM. Oxidants, antioxidants, and the degenerative disease of aging. Proc Natl Acad Sci USA 1993; 90: 7915–7922.
   PubMed Web of Science ®Google Scholar
• Berenbium I. The cocarcinogenic action of croton resin. Cancer Res 1941; 1: 44–48.
   Google Scholar
• Sun Y. Free radicals, antioxidant enzymes, and carcinogenesis. Free Radic Biol Med 1990; 8: 583–599.
   PubMed Web of Science ®Google Scholar
• McCann J, Choi E, Yamasaki E, Ames BN. Detection of carcinogens as mutagens in the Salmonellalmicrosome test: assay of 300 chemicals. Proc Natl Acad Sci USA 1975; 72: 5135–5139.
   PubMed Web of Science ®Google Scholar
• Pitot HC. Progression: the terminal stage in carcinogenesis. Jpn J Cancer Res 1989; 80: 599–607.
   PubMedGoogle Scholar
• Troll W, Wiesner R. The role of oxygen radicals as a possible mechanism of tumor promotion. Annu Rev Pharmacol Toxicol 1985; 25: 509–528.
   PubMed Web of Science ®Google Scholar
• Heppner G, Dorcey L. Macrophages and development of cancer. In: Heppner GH Fulton AM. (eds) Macrophages and Cancer. Boca Raton, FL: CRC, 1988; 197-208.
   Google Scholar
• Iversen OH. TPA (12-O-tetradecanoyi-phorbol-13-acetate) as a carcinogen for mouse skin. A positive dose-response relationship. Virchow's Arch B Cell Pathol Mol Pathol 1985; 49: 129–135.
   PubMed Web of Science ®Google Scholar
• Scherer E, Emmelot P. Kinetics of induction and growth of precancerous liver-cell foci, and liver tumour formation by diethylnitrosamine in the rat. Eur J Cancer 1975; 11: 689–696.
   PubMed Web of Science ®Google Scholar
• Birnboim HC. DNA strand breakage in human leukocytes exposed to a tumor promoter, phorbol myristate acetate. Science 1982; 215: 1247–1249.
   PubMed Web of Science ®Google Scholar
• Marx JL. Do tumor promoters affect DNA after all? Science 1983; 219: 158–159.
   PubMed Web of Science ®Google Scholar
• Slaga TJ, Fischer SM, Nelson K, Gleason GL. Studies on the mechanism of skin tumor promotion: evidence for several stages in promotion. Proc Natl Acad Sci USA 1980; 77: 3659–3663.
   PubMed Web of Science ®Google Scholar
• Boutwell RK. Diet and anticarcinogenesis in the mouse skin two-stage model. Cancer Res 1983; 43: 2464s-2468s.
   Google Scholar
• Foulds L. The experimental study of tumor progression: a review. Cancer Res 1954; 14: 327–339.
   PubMed Web of Science ®Google Scholar
• Foulds L. Multiple etiologic factors in neoplastic development. Cancer Res 1965; 25: 1339–1347.
   PubMed Web of Science ®Google Scholar
• Cerutti PA. Prooxidant states and tumor promotion. Science 1985; 227: 375–381.
   PubMed Web of Science ®Google Scholar
• Kozumbo WJ, Trush MA, Kensier TW. Are free radicals involved in tumor promotion? Chem Biol Interact 1985; 54: 199–207.
   PubMed Web of Science ®Google Scholar
• Zimmerman R, Cerutti P. Active oxygen acts as a promoter of transformation in mouse embryo C3H/10T1/2/C18 fibroblasts. Proc Natl Acad Sci USA 1984; 81: 2085–2087.
   PubMed Web of Science ®Google Scholar
• Kennedy AR, Troll W, Little JB. Role of free radicals in the initiation and promotion of radiation transformation in vitro. Carcinogenesis 1984; 5: 1213–1218.
   PubMed Web of Science ®Google Scholar
• Shamberger RJ. Increase of peroxidation in carcinogenesis. J Natl Cancer Inst 1972; 48: 1491–1497.
   PubMedGoogle Scholar
• Ito A, Watanabe H, Naito M, Naito Y. Induction of duodenal tumors in mice by oral administration of hydrogen peroxide. Gann 1981; 72: 174–175.
   PubMedGoogle Scholar
• Floyd RA, Soong LM, Stuart MA, Reigh DL. Spin trapping of free radicals produced from nitrosoamine carcinogens. Photochem Photobiol1978; 28: 857-862.
   PubMed Web of Science ®Google Scholar
• Ames BN. Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science 1983; 221: 1256–1264.
   PubMed Web of Science ®Google Scholar
• Nakayama T, Kimura T, Kodama M, Nagata C. Generation of hydrogen peroxide and superoxide anion from active metabolites of naphthylamines and aminoazo dyes: its possible role in carcinogenesis. Carcinogenesis 1983; 4: 765–769.
   PubMed Web of Science ®Google Scholar
• Pryor WA. Cancer and free radicals. In: Shankel DM, Hartman P, Kada T, Hollaender A. (eds) Antimutagenesis and Anticarcinogenesis. New York: Plenum, 1986; 45–59.
   Google Scholar
• Pryor WA. The involvement of free radicals in chemical carcinogenesis. In: Cerutti PA, Nygaard OF, Simic MG. (eds) Anticarcinogenesis and Radiation Protection. New York: Plenum, 1987; 1–9.
   Google Scholar
• Stuehr DJ, Marietta MA. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc Natl Acad Sci USA 1985; 82: 7738–7742.
   PubMed Web of Science ®Google Scholar
• Miwa M, Stuehr DJ, Marietta MA, Wishnok JS, Tannenbaum SR. Nitrosation of amines by stimulated macrophages. Carcinogenesis 1987; 8: 955–958.
   PubMed Web of Science ®Google Scholar
• Kensier TM, Trush MA. Roles of oxygen radicals in tumor promotion. Environ Mol Mutagen 1984; 6: 593–616.
   Web of Science ®Google Scholar
• Cerutti PA, Trump BF. Inflammation and oxidative stress in carcinogenesis. Cancer Cells 1991; 3: 1–7.
   PubMed Web of Science ®Google Scholar
• Irani K, Xia Y, Zweier JL et al. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 1997; 275: 1649–1652.
   PubMed Web of Science ®Google Scholar
• Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239–257.
   PubMed Web of Science ®Google Scholar
• Barr PJ, Tomei LD. Apoptosis and its role in human disease. Biotechnology 1994; 12: 487–493.
   PubMed Web of Science ®Google Scholar
• Carson DA, Ribeiro JM. Apoptosis and disease. Lancet 1994; 341: 1251–1254.
   Web of Science ®Google Scholar
• Nagata S. Apoptosis by death factor. Cell 1997; 88: 355–365.
   PubMed Web of Science ®Google Scholar
• Enari M, Sakahira H, Yokoyama H et al. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998; 391: 43–50.
   PubMed Web of Science ®Google Scholar
• Ogura T, Tatemichi M, Esumi H. Nitric oxide inhibits CPP32-like activity under redox regulation. Biochem Biophys Res Commun 1997; 236: 365–369,
   PubMed Web of Science ®Google Scholar
• Mannic JB, Asano K, Izumi K, Kieff E, Stamler JS. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell 1994; 79: 1137–1146.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86: 353–364.
   PubMed Web of Science ®Google Scholar
• Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992; 267: 10931–10934.
   PubMed Web of Science ®Google Scholar
• Brown NS, Jones A, Fujiyama C, Harris AL, Bicknell R. Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors. Cancer Res 2000; 60: 6298–6302.
   PubMed Web of Science ®Google Scholar
• Chin K, Kurashima Y, Ogura T, Tajiri H, Yoshida S, Esumi H. Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells. Oncogene 1997; 15: 437–442.
   PubMed Web of Science ®Google Scholar
• Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986,46: 6387–6392.
   PubMed Web of Science ®Google Scholar
• Wu J, Akaike T, Hayashida K, Okamoto T, Okuyama A, Maeda H. Enhanced vascular permeability in solid tumor involving peroxynitrite and matrix metalloproteinases. Jpn J Cancer Res 2001; 92: 439–451.
   PubMedGoogle Scholar
• Wu J, Akaike T, Maeda H. Modulation of enhanced vascular permeability in tumors by a bradykinin antagonist, a cyclooxygenase inhibitor, and a nitric oxide scavenger. Cancer Res 1998; 58: 159–165.
   PubMed Web of Science ®Google Scholar
• Maeda H, Noguchi Y, Sato K, Akaike T. Enhanced vascular permeability in solid tumor is mediated by nitric oxide and inhibited by both new nitric oxide scavenger and nitric oxide synthase inhibitor. Jpn J Cancer Res 1994; 85: 331–334.
   PubMedGoogle Scholar
• Himelstein BP, Canete-Soler R, Bernhard EJ, Diks DW, Muschel RJ. Metalloproteinases in tumor progression: the contribution of MMP-9. Invasion Metastasis 1994-1995; 14: 246–258.
   Google Scholar
• Chambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 1997; 89: 1260–1270.
   PubMed Web of Science ®Google Scholar
• Okamoto T, Akaike T, Sawa T, Miyamoto Y, van der Vliet A, Maeda H. Activation of matrix metalloproteinases by peroxynitrite-induced protein S-glutathiolation via disulfide 5-oxide formation. J Biol Chem 2001; 276: 29596–29602.
   PubMed Web of Science ®Google Scholar
• Akedo H, Shinkai K, Mukai M et al. Interaction of rat ascites hepatoma cells with cultured mesothelial cell layers: a model for tumor invasion. Cancer Res 1986; 46: 2416–2422.
   PubMed Web of Science ®Google Scholar
• Yoshizaki N, Mogi Y, Muramatsu H, Koike K, Kogawa K, Niitsu Y. Suppressive effect of recombinant human Cu,Zn-superoxide dismutase on lung metastasis of murine tumor cells. Int J Cancer 1994; 57: 287–292.
   PubMed Web of Science ®Google Scholar
• Imamura F, Horai T, Mukai M, Shinkai K, Akedo H. Potentiation of invasive capacity of rat ascites hepatoma cells by adriamycin. Cancer Res 1990; 50: 2018–2021.
   PubMed Web of Science ®Google Scholar
• Mogi Y, Kogawa K, Takayama T et al. Platelet aggregation induced by adenosine diphosphate released from clonal murine fibrosarcoma cells is positively correlated with the experimental metastatic potential of the cells. Jpn J Cancer Res 1991; 82: 192–198.
   PubMedGoogle Scholar
• Kogawa K, Muramatsu H, Tanaka M et al. Enhanced inhibition of experimental metastasis by the combination chemotherapy of Cu-Zn SOD and adriamycin. Clin Exp Metastasis 1999; 17:
   Google Scholar
• Li JJ, Oberley LW, Fan M, Colbum NH. Inhibition of AP-1 and NF-KB by manganese-containing superoxide dismutase in human breast cancer cells. FASEB J 1998; 12: 1713–1723.
   PubMed Web of Science ®Google Scholar
• Manna SK, Zhang HJ, Yan T, Oberley LW, Aggarwal BB. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-KB and activated protein-1. J Biol Chem 1998; 273: 13245–13254.
   PubMed Web of Science ®Google Scholar
• Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 1991; 10: 2247–2258.
   PubMed Web of Science ®Google Scholar
• Shibauma M, Kuroki T, Nose K. Stimulation by hydrogen peroxide of DNA synthesis, competence family gene expression and phosphorylation of a specific protein in quiescent Balb/3T3 cells. Oncogene 1990; 5: 1025–1032.
   PubMed Web of Science ®Google Scholar
• Amstad P, Crawford D, Muehlematter D, Zbinden I, Larsson R, Cerutti P. Oxidants stress induces the proto-oncogenes, C-fos and C-myc in mouse epidermal cells. Bull Cancer 1990; 77: 501–502.
   PubMed Web of Science ®Google Scholar
• Asahi M, Fujii J, Suzuki K et al. Inactivation of glutathione peroxidase by nitric oxide. Implication for cytotoxicity. J Biol Chem 1995; 270: 21035–21039.
   PubMed Web of Science ®Google Scholar
• Asahi M, Fujii J, Takao T et al. The oxidation of selenocysteine is involved in the inactivation of glutathione peroxidase by nitric oxide donor. J Biol Chem 1997; 272: 19152–19157.
   PubMed Web of Science ®Google Scholar
• Yamakura F, Taka H, Fujimura T, Murayama K. Inactivation of human manganese-superoxide dismutase by peroxynitrite is caused by exclusive nitration of tyrosine 34 to 3-nitrotyrosine. J Biol Chem 1998; 273: 14085–14089.
   PubMed Web of Science ®Google Scholar
• Nishizuka Y. The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 1984; 308: 693–698.
   PubMed Web of Science ®Google Scholar
• Nishizuka Y. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 1988; 334: 661–665.
   PubMed Web of Science ®Google Scholar
• Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992; 258: 607–614.
   PubMed Web of Science ®Google Scholar
• Nakamura S, Nishizuka Y. Lipid mediators and protein kinase C activation for the intracellular signaling network. J Biochem 1994; 115: 1029–1034.
   PubMed Web of Science ®Google Scholar
• Gamache DA, Fawzy AA, Franson RC. Preferential hydrolysis of peroxidized phospholipid by lysosomal phospholipase C. Biochim Biophys Acta 1988; 958: 116–124.
   PubMed Web of Science ®Google Scholar
• Ursini F, Maiorino M, Gregolin C. The selenoenzyme phospholipid hydroperoxide glutathione peroxidase. Biochim Biophys Acta 1985; 839: 62–70.
   PubMed Web of Science ®Google Scholar
• Takekoshi S, Kambayashi Y, Nagata H, Takagi T, Yamamoto Y, Watanabe K. Activation of protein kinase C by oxidized diacylglycerols. Biochem Biophys Res Commun 1995; 217: 654–660.
   PubMed Web of Science ®Google Scholar
• Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001; 357: 539–545.
   PubMed Web of Science ®Google Scholar
• Prehn RT, Lappe MA. An immunostimulation theory of tumor development. Transplant Rev 1971; 7: 26–54.
   PubMedGoogle Scholar
• Ohshima H, Bartsch H. Chronic infections and inflammatory processes as cancer risk factors; possible role of nitric oxide in carcinogenesis. Mutat Res 1994; 305: 253–564.
   PubMed Web of Science ®Google Scholar
• Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 1994; 344: 721–724.
   PubMed Web of Science ®Google Scholar
• Harris PR, Mobley HLT, Perez-Perez GI, Blaser MJ, Smith PD. Helicobacter pylori urease is a potent stimulus of mononuclear phagocyte activation and inflammatory cytokine production. Gastroenterology 1996; 111: 419–425.
   PubMed Web of Science ®Google Scholar
• Kozol R, Domanowski A, Jaszewski R et al. Neutrophil chemotaxis in gastric mucosa: a signal-to-response comparison. Dig Dis Sci 1991; 36: 1277–1280.
   PubMed Web of Science ®Google Scholar
• Bayerdorffer E, Lehn N, Hatz R et al. Difference in expression of Helicobacter pylori gastritis in antrum and body. Gastroenterology 1992; 102: 1575–1582.
   PubMed Web of Science ®Google Scholar
• Mai UE, Perez-Perez GI, Wahl LM, Wahl SM, Blaser MJ, Smith PD. Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism. J Clin Invest 1991; 87: 894–900.
   PubMed Web of Science ®Google Scholar
• Neilsen H, Andersen LP. Chemotactic activity of Helicobacter pylori sonicate for human polymorphonuclear leukocytes and monocytes. Gut 1992; 33: 738–742.
   PubMed Web of Science ®Google Scholar
• Mai UEH, Perez-Perez GI, Allen JB, Wahl SM, Blaser MJ, Smith PD. Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa. J Exp Med 1992; 175: 517–525.
   PubMed Web of Science ®Google Scholar
• Higashi H, Tsutsumi R, Muto S et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 2002; 295: 683–686.
   PubMed Web of Science ®Google Scholar
• Haswell-Elkins MR, Satarug S, Elkins DB. Opistorchis viverrini infection in northeast Thailand and its relationship to cholangiocarcinoma. J Gastroenterol Hepatol 1992; 7: 538–548.
   PubMed Web of Science ®Google Scholar
• Ohshima H, Brouet IM, Bandaletova T et al. Polydonal antibody against an inducible form of nitric oxide synthase purified from the liver of rats treated with Propionibacterium acnes and lipopolysaccharide. Biochem Biophys Res Commun 1992; 187: 1291–1297.
   PubMed Web of Science ®Google Scholar
• La Vecchia C, Negri E, D'Avanzo B, Savoldelli R, Franceschi S. Genital and urinary tract diseases and bladder cancer. Cancer Res 1991; 51: 629–631.
   PubMed Web of Science ®Google Scholar
• Davis CP, Cohen MS, Gruber MB, Anderson MD, Warren MM. Urothelial hyperplasia and neoplasia: a response to chronic urinary tract infections in rats. J Urol 1984; 132: 1025–1031.
   PubMed Web of Science ®Google Scholar
• Tiollais P, Pourcel C, Dejean A. The hepatitis B virus. Nature 1985; 317: 489–495.
   PubMed Web of Science ®Google Scholar
• Hayashi J, Aoki H, Arakawa Y, Hino O. Hepatitis C virus and hepatocarcinogenesis. Intervirology 1999; 42: 205–210.
   PubMed Web of Science ®Google Scholar
• Himeno Y, Fukuda Y, Hatanaka M, Imura H. Expression of oncogenes in human liver disease. Liver 1988; 8: 208–212.
   PubMedGoogle Scholar
• Pasquinelli C, Bhavani K, Chisari FV. Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice. Cancer Res 1992; 52: 2823–2829.
   PubMed Web of Science ®Google Scholar
• Hsu IC, Tokiwa T, Bennett W et al. p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines. Carcinogenesis 1993; 14: 987–992.
   PubMed Web of Science ®Google Scholar
• Kuroki T, Fujiwara Y, Tsuchiya E et al. Accumulation of genetic changes during development and progression of hepatocellular carcinoma: loss of heterozygosity on chromosome arm lp occurs at an early stage of hepatocarcinogenesis. Genes Chromosomes Cancer 1995; 13: 163–167.
   PubMed Web of Science ®Google Scholar
• Hagen TM, Huang S, Curnutte J et al. Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma. Proc Natl Acad Sci USA 1994; 91: 12808–12812.
   PubMed Web of Science ®Google Scholar
• Kato J, Kobune M, Nakamura T et al. Normalization of elevated hepatic 8-hydroxy-2-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet. Cancer Res 2001; 61: 8697–8702.
   PubMed Web of Science ®Google Scholar
• Weitzman SA, Gordon LI. Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis. Blood 1990; 76: 655–663.
   PubMed Web of Science ®Google Scholar
• Kasai H, Nishimura S. Hydroxylation of guanine in nucleosides and DNA at the C-8 position by heated glucose and oxygen radical-forming agents. Environ Health Perspect 1986; 67: 111–116.
   PubMed Web of Science ®Google Scholar
• Cheng KC, Cahill DS, Kasai H, Nishimura S, Loeb LA. 8- Hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions. J Biol Chem 1992; 267: 166–172.
   PubMed Web of Science ®Google Scholar
• Yamashita S, Yamamoto Y. Simultaneous detection of ubiquinol and ubiquinone in human plasma as a marker of oxidative stress. Anal Biochem 1997; 250: 66–73.
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Yamashita S, Fujisawa A, Kokura S, Yoshikawa T. Oxidative stress in patients with hepatitis, cirrhosis, and hepatoma evaluated by plasma antioxidants. Biochem Biophys Res Commun 1998; 247: 166–170.
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Wakabayashi K, Niki E, Nagao M. Comparison of plasma levels of lipid hydroperoxides and antioxidants in hyperlipidemic Nagase analbuminemic rats, Sprague-Dawley rats, and humans. Biochem Biophys Res Commun 1992; 189: 518–523.
   PubMed Web of Science ®Google Scholar
• Badwey JA, Karnovsky ML. Active oxygen species and the functions of phagocytic leukocytes. Annu Rev Biochem 1980; 49: 695–726.
   PubMed Web of Science ®Google Scholar
• Weitzman SA, Stossel TP. Mutation caused by human phagocytes. Science 1981; 212: 546–547.
   PubMed Web of Science ®Google Scholar
• Weitzman SA, Stossel TP. Effects of oxygen radical scavengers and antioxidants on phagocyte induced mutagenesis. J Immunol 1982; 128: 2770–2772.
   PubMed Web of Science ®Google Scholar
• Barak M, Ulitzur S, Merzbach D. Phagocytosis- inducedmutagenesis in bacteria. Mutat Res 1983; 121: 7–16.
   PubMed Web of Science ®Google Scholar
• Fulton AM, Loveless SE, Heppner GH. Mutagenic activity of tumor-associated macrophages in Salmonella typhimurium strains TA98 and TA100. Cancer Res 1984; 44: 4308–4311.
   PubMed Web of Science ®Google Scholar
• Weitzman SA, Stossel TP. Phagocyte-induced mutation in Chinese hamster ovary cells. Cancer Lett 1984; 22: 337–341.
   PubMed Web of Science ®Google Scholar
• Yamashina K, Miller BE, Heppner GH. Macrophage-induced induction of drug-resistance variants in a mouse mammary tumor cell line. Cancer Res 1986; 46: 2396–2401.
   PubMed Web of Science ®Google Scholar
• Weitzman SA, Weitb erg AB, Clark EP, Stossel TP. Phagocytes as carcinogens: malignant transformation produced by human neutrophils. Science 1985; 227: 1231–1233.
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Wu HI-L Momose H, Rademaker A, Oyasu R. Marked enhancement of rat urinary bladder carcinogenesis by heat-killed Escherichia coli. Cancer Res 1992; 52: 5329–5333.
   Google Scholar
• Kawai K, Yamamoto M, Kameyama S, Kawamata H, Rademaker A, Oyasu R. Enhancement of rat urinary bladder tumorigenesis by lipopolysaccharide-induced inflammation. Cancer Res 1993; 53: 5172–5175.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Sendo F, Shirai T, Kaji H, Kodama T. Modification in growth of transplantable rat tumors exposed to Friend virus. J Natl Cancer Inst 1969; 42: 413–419.
   PubMed Web of Science ®Google Scholar
• Itaya T, Yamagiwa S, Okada F et al. Xenogenization of a mouse lung carcinoma (3LL) by transfection with an allogeneic class I major histocompatibility complex gene (H-20). Cancer Res 1987; 47: 3136–3140.
   PubMed Web of Science ®Google Scholar
• Ishikawa M, Okada F, Hamada J-I, Hosokawa M, Kobayashi H. Changes in the tumorigenic and metastatic properties of tumor cells treated with quercetin or 5-azacytidine. Int J Cancer 1987; 39: 338–342.
   PubMed Web of Science ®Google Scholar
• Okada F, Hosokawa M, Hasegawa J et al. Regression mechanisms of mouse fibrosarcoma cells after in vitro exposure to quercetin: diminution of tumorigenicity with a corresponding decrease in the production of prostaglandin E2. Cancer Immunol Immunother 1990; 31: 358–354.
   PubMed Web of Science ®Google Scholar
• Okada F, Hosokawa M, Hamada J-I et al. Malignant progression of a mouse fibrosarcoma by host cells reactive to a foreign body (gelatin sponge). Br J Cancer 1992; 66: 635–639.
   PubMed Web of Science ®Google Scholar
• Young MR, Okada F, Tada M, Hosokawa M, Kobayashi H. Association of increased tumor cell responsiveness to prostaglandin E2 with more aggressive tumor behavior. Invasion Metastasis 1991; 11: 48–57.
   PubMedGoogle Scholar
• Ren J, Hamada J, Okada F et al. Correlation between the presence of microvilli and the growth or metastatic potential of tumor cells. Jpn J Cancer Res 1990; 81: 920–926.
   PubMedGoogle Scholar
• Kobayashi T, Okada F, Fujii N et al. Thymosin 134 regulates motility and metastasis of malignant mouse fibrosarcoma cells. Am J Pathol 2002; 160: 869–882.
   PubMed Web of Science ®Google Scholar
• Habelhah H, Okada F, Kobayashi M et al. Increased ElAF expression in mouse fibrosarcoma promotes metastasis through induction of MT1-MMP expression. Oncogene 1999; 18: 1771–1776.
   PubMed Web of Science ®Google Scholar
• Okada F, Nakai K, Kobayashi T et al. Inflammatory-cell-mediated tumour progression and minisatellite mutation correlate with the decrease of antioxidative enzymes in murine fibrosarcoma cells. Br J Cancer 1999; 79: 377–385.
   PubMed Web of Science ®Google Scholar
• Habelhah H, Okada F, Nakai K et al. Polysaccharide K induces Mn superoxide dismutase (Mn-SOD) in tumor tissues and inhibits malignant progression of QR-32 tumor cells: possible roles of interferon a, tumor necrosis factor a and transforming growth factor p in Mn-SOD induction by polysaccharide K. Cancer Immunol Immunother 1998; 46: 338–344.
   PubMed Web of Science ®Google Scholar
• Hamada J-I, Takeichi N, Okada F et al. Progression of weakly malignant clone cells derived from rat mammary carcinoma by host cells reactive to plastic plates. Jpn J Cancer Res 1992; 83: 483–490.
   PubMedGoogle Scholar
• Li X, Nagayasu H, Hamada J-I, Hosokawa M, Takeichi N. Enhancement of tumorigenicity and invasion capacity of rat mammary adenocarcinoma cells by epidermal growth factor and transforming growth factor-13. Jpn J Cancer Res 1993; 84: 1145–1149.
   PubMedGoogle Scholar
• Hamada J-I, Nagayasu H, Takayama M, Kawano T, Hosokawa M, Takeichi N. Enhanced effect of characterization of epidermal growth factor on pulmonary metastasis and in vitro invasion of rat mammary carcinoma cells. Cancer Lett 1995; 89: 161–167.
   PubMed Web of Science ®Google Scholar
• Nagayasu H, Hamada J-I, Nakata D et al. Reversible and irreversible tumor progression of a weakly malignant rat mammary carcinoma cell line by in vitro exposure to epidermal growth factor. Int J Oncol 1998; 12: 197–202.
   PubMed Web of Science ®Google Scholar
• Hamada J-I, Nakata D, Nakae D et al. Increased oxidative DNA damage in mammary tumor cells by continuous epidermal growth factor stimulation. J Natl Cancer Inst 2001; 93: 214–219.
   PubMedGoogle Scholar
• Okada F, Kawaguchi T, Habelhah H et al. Conversion of human colonic adenoma cells to adenocarcinoma cells through inflammation in nude mice. Lab Invest 2000; 80: 1617–1628.
   PubMed Web of Science ®Google Scholar
• Kawaguchi T, Miyaki M, Masui T et al. Establishment and characterization of epithelial cell line with quasi-normal chromosomes from a tubular adenoma of a familial polyposis coli patient. Jpn J Cancer Res 1991; 82: 138–141.
   PubMedGoogle Scholar
• Kerbel RS, Frost P, Liteplo R, Carlow DA, Elliott BE. Possible epigenetic mechanisms of tumor progression: induction of high-frequency heritable but phenotypically unstable changes in the tumorigenic and metastatic properties of tumor cell populations by 5-azacytidine treatment. J Cell Physiol Suppl 1984; 3: 87–97.
   PubMedGoogle Scholar
• Boone CW, Takeichi N, del Ande ES, Paranjpe M. ‘Spontaneous’ neoplastic transformation in vitro: a form of foreign body (smooth surface) tumorigenesis. Science 1979; 204: 177–179.
   PubMed Web of Science ®Google Scholar
• Boone CW, Vembu D, White BJ, Takeichi N, Paranjpe M. Karyotypic, antigenic, and kidney-invasive properties of cell lines from fibrosarcomas arising in C3H/10T1/2 cells implanted subcutaneously attached to plastic plates. Cancer Res 1979; 39: 2172–2178.
   PubMed Web of Science ®Google Scholar
• Boone CW, Takeichi N, Paranjpe M, Gilden R. Vasoformative sarcomas arising from BALB/3T3 cells attached to solid substrates. Cancer Res 1976; 36: 1626–1633.
   PubMed Web of Science ®Google Scholar
• Boone CW. Malignant hemangioendotheliomas produced by subcutaneous inoculation of Balb/3T3 cells attached to glass beads. Science 1975; 188: 68–70.
   PubMed Web of Science ®Google Scholar
• Boone CW, Jacobs JF. Sarcomas routinely produced from putative non-tumorigenic BALB/3T3 and C3H/10T1/2 cells by subcutaneous inoculation attached to plastic plates. J Supramol Struct 1976; 5: 131–137.
   PubMedGoogle Scholar
• Tanaka T, Iwasa Y, Kondo S, Hiai H, Toyokuni S. High incidence of allelic loss on chromosome 5 and inactivation ofp/.5INK4B and p16INK4A tumor suppressor genes in oxystress-induced renal cellcarcinoma of rats. Oncogene 1999; 18: 3793–3797.
   Google Scholar
• Hiroyasu M, Ozeki M, Kohda H et al. Specific allelic loss of p16INK4A tumor suppressor gene after weeks of iron-mediated oxidative damage during rat renal carcinogenesis. Am J Pathol2002; 160: 419–424.
   Google Scholar